
Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …
US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …

Janssen’s new hepatitis C treatment Incivo has been launched in the UK, one of two new drugs set to advance …

Richard Clark will step down as chairman of Merck & Co on 1 December after leading the company for six …
The NHS Confederation has called on the government to be more open about cuts to the health service. The government …
Despite this comprehensive range of laboratory autoclaves there is always someone who wants something different and that is exactly what …
The order called for a total of seventy-two top-loading, 150L capacity steam sterilisers with high output/low power steam generators built-in. …
It’s surprising how many companies struggle to deliver an effective forcasting process despite the millions spent on supply chains. Accurate …

Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK. It …
Cheshire-based The Scott Partnership has acquired Phoenix Marcom, boosting its reach into the European market. The Cambridge, UK scientific marketing …

Novartis has been forced to cut the Swiss price of its eye drug Lucentis by 30% after sharp negotiations with …

Boehringer Ingelheim has signed a deal giving Gilead Sciences exclusive worldwide rights to a major part of its HIV portfolio. …
TogoRun has appointed Mary Hicks as a director at its London office.She joins the agency from Clew Communications, where she …
The government has established a new research institute to aid public and private groups working on the early stages of …
The Department of Health has appointed Sam Lister, currently health editor at The Times, as its new director of communications. …
Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …

The European Medicines Agency is tightening up its conflict of interest rules with a new ‘experts database’. This will allow …
Cuong Viet Do has joined Merck & Co as chief strategy officer, replacing Mervyn Turner who retired from the US …
There should be free access to all clinical trials in order to end selective reporting, according to a leading not-for-profit …

Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …